These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 27379946)

  • 1. Update on the biology and management of neuroendocrine prostate cancer.
    Beltran H
    Clin Adv Hematol Oncol; 2016 Jul; 14(7):513-5. PubMed ID: 27379946
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of prostate neuroendocrine cancers and therapeutic management: a literature review.
    Sargos P; Ferretti L; Gross-Goupil M; Orre M; Cornelis F; Henriques de Figueiredo B; Houédé N; Merino C; Roubaud G; Dallaudiére B; Richaud P; Fléchon A
    Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):220-6. PubMed ID: 24796290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges in recognizing treatment-related neuroendocrine prostate cancer.
    Beltran H; Tagawa ST; Park K; MacDonald T; Milowsky MI; Mosquera JM; Rubin MA; Nanus DM
    J Clin Oncol; 2012 Dec; 30(36):e386-9. PubMed ID: 23169519
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical Features of Treatment-related Neuroendocrine Prostate Cancer: A Case Series.
    Suzuki K; Terakawa T; Jimbo N; Inaba R; Nakano Y; Fujisawa M
    Anticancer Res; 2020 Jun; 40(6):3519-3526. PubMed ID: 32487653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Neuroendocrine prostate cancer].
    Kretschmer A; Wittekind C; Stief CG; Gratzke C
    Urologe A; 2015 Dec; 54(12):1779-83. PubMed ID: 26582381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic Spectrum of Neuroendocrine Tumors of the Prostate: An Updated Review.
    Hu J; Han B; Huang J
    Arch Pathol Lab Med; 2020 Mar; 144(3):320-325. PubMed ID: 31644322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies.
    Conteduca V; Aieta M; Amadori D; De Giorgi U
    Crit Rev Oncol Hematol; 2014 Oct; 92(1):11-24. PubMed ID: 24952997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroendocrine cancer of the prostate. A series of 6 cases].
    Breton X; Plazanet C; Murat FJ; Milinkevitch S; Irani J; Levillain P; Doré B
    Prog Urol; 2003 Dec; 13(6):1340-4. PubMed ID: 15000310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum chromogranin A in prostate cancer].
    Akakura K
    Nihon Rinsho; 2002 Dec; 60 Suppl 11():160-4. PubMed ID: 12599564
    [No Abstract]   [Full Text] [Related]  

  • 10. [Left supraclavicular adenopathy with a neuroendocrine pattern of unknown cause: prostatic carcinoma metastasis].
    Fernández Borrell A; Peinado Ibarra F; Gómez Sancha F; Teba del Pino F; Minguez Martínez R; Morato Robert P; Arellano Gañan R; Romero Tejada JC; Pereira Sanz I
    Actas Urol Esp; 1999; 23(7):603-8. PubMed ID: 10488615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Giant neuroendocrine tumor of the prostate].
    Kuenkel MR; Parra Muntaner L; Martorell Mateu ME
    Actas Urol Esp; 2009 Sep; 33(8):933. PubMed ID: 19900394
    [No Abstract]   [Full Text] [Related]  

  • 12. Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.
    Ramage JK; Davies AH; Ardill J; Bax N; Caplin M; Grossman A; Hawkins R; McNicol AM; Reed N; Sutton R; Thakker R; Aylwin S; Breen D; Britton K; Buchanan K; Corrie P; Gillams A; Lewington V; McCance D; Meeran K; Watkinson A;
    Gut; 2005 Jun; 54 Suppl 4(Suppl 4):iv1-16. PubMed ID: 15888809
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of Neuroendocrine Tumors in the Twenty-First Century.
    Ioachimescu AG
    Endocrinol Metab Clin North Am; 2018 Sep; 47(3):xiii-xiv. PubMed ID: 30098727
    [No Abstract]   [Full Text] [Related]  

  • 14. Cases in the Management of GEP-NETs: The Use of Surgery, an Underutilized Option in the Management of Advanced-Stage NETs.
    Boudreaux JP
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):7-11. PubMed ID: 27167992
    [No Abstract]   [Full Text] [Related]  

  • 15. Laboratory tests for neuroendocrine tumours.
    Seregni E; Ferrari L; Stivanello M; Dogliotti L
    Q J Nucl Med; 2000 Mar; 44(1):22-41. PubMed ID: 10932599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic neuroendocrine tumors: a review.
    Young K; Iyer R; Morganstein D; Chau I; Cunningham D; Starling N
    Future Oncol; 2015; 11(5):853-64. PubMed ID: 25757686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cases in the Management of GEP-NETs: Combination Regimens.
    Braiteh F
    Clin Adv Hematol Oncol; 2016 Apr; 14(4 Suppl 6):11-3. PubMed ID: 27167993
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroendocrine tumours emerge from the shadows.
    Gilbert JA
    Lancet Diabetes Endocrinol; 2017 Jul; 5(7):498. PubMed ID: 27818210
    [No Abstract]   [Full Text] [Related]  

  • 19. Neuroendocrine tumors, version 1.2015.
    Kulke MH; Shah MH; Benson AB; Bergsland E; Berlin JD; Blaszkowsky LS; Emerson L; Engstrom PF; Fanta P; Giordano T; Goldner WS; Halfdanarson TR; Heslin MJ; Kandeel F; Kunz PL; Kuvshinoff BW; Lieu C; Moley JF; Munene G; Pillarisetty VG; Saltz L; Sosa JA; Strosberg JR; Vauthey JN; Wolfgang C; Yao JC; Burns J; Freedman-Cass D;
    J Natl Compr Canc Netw; 2015 Jan; 13(1):78-108. PubMed ID: 25583772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GEP-NETs UPDATE: Secreting gastro-enteropancreatic neuroendocrine tumours and biomarkers.
    Verbeek WH; Korse CM; Tesselaar ME
    Eur J Endocrinol; 2016 Jan; 174(1):R1-7. PubMed ID: 26162406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.